JAMES CZABAN, a partner and chair of the U.S. Food and Drug Administration practice group at Wiley Rein in Washington, D.C., has joined DLA Piper.
The global legal giant, which saw gross revenue break the $2.5 billion mark for the first time in 2015, added Czaban to its international trade, government affairs, life sciences and regulatory groups in the nation’s capital. Czaban, who enjoys fishing vacations, comes to DLA Piper after seven years at Wiley Rein, whose food, drug and product safety practice he joined back in 2009 after co-chairing the FDA group at Wilmer Cutler Pickering Hale and Dorr.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
